Abstract | OBJECTIVES: METHODS: Cats with histologically verified SCC of the head and neck received an intravenous injection of liposomal phosphorylated meta-tetra(hydroxylphenyl) chlorine ( mTHPC) and 4 h later 652 nm light was delivered by a diode laser. One group received ⩽10 J/cm2, the other 20 J/cm2. Tumour response and duration were analysed with stage, tumour diameter, location and treatment intensity as prognostic factors. RESULTS: In total, 63 lesions in 38 cats underwent treatment with ⩽10 J/cm2 (n = 22) and 20 J/cm2 (n = 41). Overall response rate was 84% (complete remission 61%, partial remission 22%) with a mean progression-free interval of 35 months (median not reached) and a median overall survival time of 40 months (95% confidence interval 33-47). With regard to tumour stage, invasiveness yielded a highly significant worse outcome ( P <0.017). All patients with invasive tumours showed progression at less than 6 months. Larger lesions were associated with inferior control and treatment intensity, and tumour location did not influence response and duration. CONCLUSIONS AND RELEVANCE:
PDT using a systemic photosensitiser leads to excellent long-term tumour control in the majority of cats. However, invasive and large tumours had a clearly inferior outcome, even if treated with the higher-dose intensity. This suggests that advanced lesions are not indications for PDT.
|
Authors | Irene Flickinger, Eva Gasymova, Simona Dietiker-Moretti, Alexander Tichy, Carla Rohrer Bley |
Journal | Journal of feline medicine and surgery
(J Feline Med Surg)
Vol. 20
Issue 12
Pg. 1100-1104
(12 2018)
ISSN: 1532-2750 [Electronic] England |
PMID | 29359611
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Mesoporphyrins
- Photosensitizing Agents
- temoporfin
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Carcinoma, Squamous Cell
(therapy, veterinary)
- Cat Diseases
(drug therapy, therapy)
- Cats
- Female
- Head and Neck Neoplasms
(therapy, veterinary)
- Male
- Mesoporphyrins
(therapeutic use)
- Photochemotherapy
(veterinary)
- Photosensitizing Agents
(therapeutic use)
- Prognosis
|